Beijing Changcheng Pharmaceutical

Beijing Changcheng Pharmaceutical Co., Ltd. (formerly Beijing Changcheng Pharmaceutical Factory) is a state-owned pharmaceutical company founded in 1980 and based in Beijing, China. The company specializes in the research, development, and manufacturing of traditional Chinese patent medicines (TCM) and modern pharmaceuticals across seven dosage forms, including tablets, granules, soft capsules, hard capsules, oral liquids, lotions, and mixtures. Its product portfolio features over 50 products, with key brands such as Xiao'er Qingfei Huatan Granules, Qinglin Granules, and Huoxue Jiangu Tablets. In 2018, China Meheco Co., Ltd. acquired a 51% controlling stake in the company, integrating it into the Genertec group to resolve peer competition and expand its TCM business.